Here are five key points:
1. Mouen Khashab, MD, associate professor of medicine and director of therapeutic endoscopy at The Johns Hopkins Hospital, performed the procedure.
2. The MUSE system is used in an incisionless procedure for the long-term treatment of gastroesophageal reflux disease.
3. The incisionless procedure, made possible by the MUSE system, allows for shorter hospital stays and reduced post-procedure medications.
4. The system is fully integrated with leading microvisual, ultrasonic and stapling technology.
5. Medigus a medical device company focused on developing minimally invasive endosurgical tools and direct visualization technology.
More articles on GI/endoscopy:
Boston Scientific sales hit $1.76B, PENTAX names new CMO, COO & more – 5 GI/endoscopy company key notes
38% of upper endoscopies do not follow acid reflux testing guidelines: 5 things to know
Colonoscopy vs. capsule endoscopy: 3 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
